🔗 Share this article

This year's Nobel Prize in Physiology or Medicine has been granted for transformative discoveries that illuminate how the body's defense network attacks dangerous infections while sparing the body's own cells.

Three renowned scientists—Japan's Shimon Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

The research uncovered specialized "security guards" within the defense system that remove rogue immune cells capable of attacking the organism.

These discoveries are now paving the way for innovative therapies for autoimmune diseases and cancer.

These laureates will divide a monetary award valued at 11 million Swedish kronor.

Crucial Discoveries

"Their work has been essential for comprehending how the immune system functions and the reason we don't all develop serious self-attack conditions," stated the chair of the Nobel Committee.

The trio's studies explain a fundamental question: How does the defense system defend us from numerous infections while leaving our own tissues unharmed?

The immune system employs white blood cells that scan for signs of infection, including viruses and bacteria it has never encountered.

These defenders employ sensors—known as receptors—that are produced randomly in a vast number of combinations.

That provides the immune system the ability to combat a wide array of invaders, but the unpredictability of the mechanism inevitably produces immune cells that can attack the body.

Security Guards of the Immune System

Researchers previously knew that a portion of these problematic white blood cells were eliminated in the thymus—the site where white blood cells develop.

This year's Nobel Prize recognizes the discovery of regulatory T-cells—known as the body's "peacekeepers"—which travel through the body to neutralize other defenders that assault the body's own tissues.

We know that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel added, "These discoveries have laid the foundation for a novel area of research and spurred the creation of new therapies, for instance for cancer and immune disorders."

In malignancies, T-regs prevent the system from fighting the tumor, so studies are focused on reducing their numbers.

For self-attack disorders, experiments are exploring boosting regulatory T-cells so the body is no longer being harmed. A similar method could also be useful in reducing the chances of transplanted organ rejection.

Pioneering Experiments

Prof Sakaguchi, of a Japanese institution, conducted tests on rodents that had their thymus extracted, leading to autoimmune disease.

He demonstrated that introducing defense cells from other animals could stop the illness—suggesting there was a system for preventing immune cells from harming the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an inherited autoimmune disease in mice and humans that led to the discovery of a genetic factor critical for how T-regs function.

"Their groundbreaking research has revealed how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly targeting the healthy cells," said a leading physiology expert.

"This work is a remarkable illustration of how basic biological study can have far-reaching consequences for human health."